Skip to main navigation Skip to search Skip to main content

CTU: A Phase 2 Open-label Randomized Study of V940 in Combination With BCG Versus BCG Monotherapy in Participants With High-risk Non-muscle Invasive Badder Cancer (INTerpath-011)

  • Zhang, Alison (Primary Chief Investigator)
  • Quinlan, Gabriel (Clinical Trial Unit Staff)
  • Martin, Lewis (Clinical Trial Unit Staff)
  • Garcia, Michelle (Clinical Trial Unit Staff)
  • Armstrong, Emilia (Clinical Trial Unit Staff)

Project: Research

Project Details

Short titleV940-011
AcronymINTerpath-011
StatusActive
Effective start/end date6/03/2515/01/30